FHA
TTNP

Flagship Harbor Advisors’s Titan Pharmaceuticals TTNP Stock Holding History

Flagship Harbor Advisors’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed – – 1675
2020
Q3 		$0 Hold
1
– – ﹤0.01% 2161
2020
Q2 		$0 Hold
1
– – ﹤0.01% 2156
2020
Q1 		$0 Hold
1
– – ﹤0.01% 1974
2019
Q4 		$0 Hold
1
– – ﹤0.01% 1956
2019
Q3 		$0 Hold
1
– – ﹤0.01% 1967
2019
Q2 		$0 Hold
1
– – ﹤0.01% 1980
2019
Q1 		$0 Hold
1
– – ﹤0.01% 1955
2018
Q4 		$0 Hold
1
– – ﹤0.01% 2096
2018
Q3 		$0 Hold
1
– – ﹤0.01% 2144
2018
Q2 		$2K Buy
+1
New +$3.35K ﹤0.01% 1878

Other funds holding TTNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TI
tru Independence Portland, Oregon $202M AUM 15.81% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Flagship Harbor Advisors's TTNP Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Titan Pharmaceuticals (TTNP) in Q4 2020, closing a stake of 1 share.

Flagship Harbor Advisors first reported a position in TTNP in Q2 2018 and held it in 10 quarters. The position peaked at $2K in Q2 2018. 15 funds tracked by Wall St. Rank hold TTNP as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Titan Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 1 Titan Pharmaceuticals share in Q4 2020.
  • Flagship Harbor Advisors first reported a position in Titan Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Titan Pharmaceuticals position peaked at $2K in Q2 2018.
  • 15 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.